Metabolic-Fit / 100
Bodi Envi review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Semaglutide: $155/mo advertised sale; tirzepatide: $229/mo advertised sale. These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Bodi Envi at a glance
- Semaglutide
- $155/mo advertised sale
- Tirzepatide
- $229/mo advertised sale
- Coverage
- Does not disclose its own state list (only its pharmacy's licensing)
- Brand-name
- Compounded only
How we scored Bodi Envi
Every factor comes from Bodi Envi's own published pricing, disclosures and oversight, and the six combine into the 39/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
Semaglutide: $155/mo advertised sale; tirzepatide: $229/mo advertised sale. These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration.
Before you sign up
What Bodi Envi's public site and signup page show before you hand over any details.
Worth knowing
- The intake runs on Shopify rather than on the provider's own software
- No monthly price is visible on the public homepage; the number appears only after you begin the intake
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $155 | All doses$155/mo advertised sale. These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration. |
| Compounded tirzepatide | $229 | All doses$229/mo advertised sale. These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Bodi Envi's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Semaglutide: $155/mo advertised sale; tirzepatide: $229/mo advertised sale.
- Named, checkable founders (Ashley and Shaun Padgett) rather than an anonymous team
- 24/7 secure provider messaging and personalized dose titration
- Free 2-day shipping; FSA/HSA eligible
The caveats
- These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration.
- Its only state-coverage claim is its pharmacy's own licensing, not Bodi Envi's confirmation it serves your state
- No postpartum, breastfeeding or PCOS-specific guidance found
- No brand-name (Wegovy/Zepbound) pathway
The current sale amount needs a renewal explanation
Bodi Envi advertises semaglutide at $155 per month and tirzepatide at $229 per month as sale amounts, beside reference figures of $179 and $249. The public offer does not settle the sale’s duration or the amount charged when it ends. Obtain the first payment and the continuing renewal amount together before treating either sale figure as a permanent budget.
The higher reference prices should not automatically be assumed to be the next charge either. They are displayed anchors, while the actual agreement must identify what a new patient will pay. A reader comparing providers needs the selected drug, prescribed quantity, billing period and renewal conditions, rather than the largest-looking saving on a product card.
Named founders and pharmacy provide useful accountability
Bodi Envi identifies founders Ashley and Shaun Padgett, described as former owners of a Florida clinic. That is more business background than an anonymous storefront provides. It does not establish either person’s medical licensure or mean that a founder personally treats the patient. Ask who is responsible for the clinical assessment and ongoing prescribing.
The seller names VialsRx as its compounding pharmacy partner. That gives the patient an identifiable fulfillment organization to investigate. Confirm the pharmacy assignment for the actual prescription, along with ingredients, concentration, quantity and storage instructions. A named pharmacy is useful transparency, but it does not make a compounded finished product FDA-approved.
Pharmacy licensing is not the service’s state list
Bodi Envi’s state-related statement concerns VialsRx’s licensing in all 50 states. That is a claim about the pharmacy, not confirmation that Bodi Envi’s clinical service can treat a patient in every state. The distinction matters before starting an assessment or relying on a price for a location the medical team may not serve.
Request confirmation that both the clinician and pharmacy can provide the selected service where the patient is located. An online platform may involve several organizations with different responsibilities and footprints. Identifying the medical practice as well as the pharmacy makes it easier to understand who answers treatment questions and who handles the dispensed product or shipment.
Messaging and shipping are promises to define
The program advertises secure provider messaging around the clock, personalized dose adjustment and free two-day shipping, without separate consultation or membership fees in the earlier description. Confirm those inclusions against the current sale plan. Around-the-clock messaging access does not necessarily mean an immediate response from the prescribing professional at every hour.
Likewise, establish when the shipping estimate begins and how delays or delivery-condition concerns are handled. Ask how a prescription change reaches the pharmacy before another order is prepared, and what the actual cancellation deadline is. Neither a messaging promise nor a quick shipping claim establishes a general refund right for medication already dispensed.
The compounding disclosure should remain part of the choice
Bodi Envi explicitly states that its compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness or quality. That is a meaningful disclosure to preserve alongside the sales offer. The program does not establish an approved-brand Wegovy or Zepbound route in the menu reviewed here.
Its public material also does not set out dedicated postpartum, breastfeeding or PCOS guidance. Bodi Envi may interest someone who values a named founder team, named pharmacy and messaging access. The remaining decision depends on the current all-in quote, state eligibility and responsible clinician, with the sale duration and next charge resolved before relying on the advertised monthly amount.
The bottom line for mothers
Best for: Readers who can compare the full payment commitment and confirm the renewal amount before choosing a plan.
Alternatives to Bodi Envi
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit Enhance MD81
Metabolic-Fit / 100
A compounded program that advertises ongoing provider care, metabolic testing every six months and shipping within its price. Semaglutide is $249 and tirzepatide $329 every four weeks without a longer commitment; lower equivalents require 12-, 24- or 48-week terms. Microdose and combination options need separate current quotes.
- Visit Peter MD36
Metabolic-Fit / 100
Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with a strict cancellation policy that refuses cancellations inside 48 hours of a renewal.
Providers like Bodi Envi
Keep comparing Bodi Envi
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Bodi Envi, answered
- How much does Bodi Envi actually cost?
- Semaglutide: $155/mo advertised sale; tirzepatide: $229/mo advertised sale. These are advertised sale amounts against $179 and $249 reference prices; confirm the renewal amount and sale duration.
- Does Bodi Envi serve my state?
- Bodi Envi itself doesn't publish a state list. The only coverage claim on the site is that its compounding pharmacy, VialsRx, is licensed in all 50 states — that's the pharmacy's own licensing, not Bodi Envi's confirmation that it ships to you. Confirm directly before paying.
- Who founded Bodi Envi and who fills the prescription?
- Ashley and Shaun Padgett, former owners of a Florida clinic, founded Bodi Envi — a named, checkable founder team. Prescriptions are compounded through VialsRx, a named pharmacy partner.
Pricing, states and verification reflect Bodi Envi's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.